| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 142,088 | 202,134 | 185,753 | 200,651 | | Cost of Revenue | 129,599 | 187,020 | 184,429 | 218,623 | | | Gross Profit | 12,489 | 15,114 | 1,324 | (17,972) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,492 | 25,935 | 20,445 | 36,956 | | Non Recurring | 1,018 | 174 | 17,991 | 75,008 | | Others |
-
|
-
|
-
| 1,309 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (673) | (10,995) | (37,112) | (131,245) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 256 | (93,486) | (1,461) | (6,716) | | Earnings Before Interest And Taxes | (765) | (104,481) | (38,573) | (137,961) | | Interest Expense | 14,366 | 18,554 | 17,711 | 16,928 | | Income Before Tax | (15,131) | (123,035) | (56,284) | (154,889) | | Income Tax Expense | (571) | 3,565 | (1,136) | 3,418 | | Minority Interest | 7,240 | (2,797) | 2,797 | 4,101 | | | | Net Income From Continuing Ops | (7,183) | (129,343) | (52,178) | (154,353) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,183) | (129,343) | (52,178) | (154,353) | | Preferred Stock And Other Adjustments | (9,653) | 585 | (4,336) | (4,349) | | | Net Income Applicable To Common Shares | ($16,836) | ($128,758) | ($56,514) | ($158,702) |
|
0.20% Nasdaq 
Income Statement
